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We have recently shown that increased hydrogen peroxide (H2O2) generation is involved in hypoxia–
ischemia (HI)-mediated neonatal brain injury. H2O2 can react with free iron to form the hydroxyl radical,
through Fenton Chemistry. Thus, the objective of this study was to determine if there was a role for the
hydroxyl radical in neonatal HI brain injury and to elucidate the underlying mechanisms. Our data de-
monstrate that HI increases the deposition of free iron and hydroxyl radical formation, in both P7 hip-
pocampal slice cultures exposed to oxygen–glucose deprivation (OGD), and the neonatal rat exposed to
HI. Both these processes were found to be nitric oxide (NO) dependent. Further analysis demonstrated
that the NO-dependent increase in iron deposition was mediated through increased transferrin receptor
expression and a decrease in ferritin expression. This was correlated with a reduction in aconitase ac-
tivity. Both NO inhibition and iron scavenging, using deferoxamine administration, reduced hydroxyl
radical levels and neuronal cell death. In conclusion, our results suggest that increased NO generation
leads to neuronal cell death during neonatal HI, at least in part, by altering iron homeostasis and hy-
droxyl radical generation.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Neonatal hypoxia–ischemia (HI) remains an important cause of
acute mortality and chronic morbidity in infants and children. The
neurologic consequences of injury include mental retardation,
epilepsy, cerebral palsy, and blindness [1]. Despite progress in
obstetric and neonatal care, the current clinical treatments for
neonatal HI brain injury are mainly supportive. The mechanisms
underlying the brain injury associated with HI is only partly un-
derstood. Although increasing evidence indicates that free radicals
and reactive oxygen species are important mediators of ischemic
neuronal death [2–4], little is known regarding their speciﬁc cel-
lular sources and how they are regulated. Our previous studies
have shown that there is increased superoxide and hydrogen
peroxide (H2O2) production in the HI-exposed neonatal brain [5,6]
and this is mediated at least in part via NADPH oxidase brain [5].
The neonatal brain also has a low with antioxidant capacity, in-
cluding limited GPx activity [7,8] and increasing GPx activity is
neuroprotective [5]. The iron-catalyzed formation of hydroxylB.V. This is an open access article u
. Black).radical from H2O2 is also recognized as a potent oxidant that can
cause cell damage. However, its role in neonatal HI brain injury is
unresolved. The neonatal brain accumulates more ferrous and
ferric iron than older animals [9–11]. Iron uptake in the neonatal
rat brain is also high, reaching a peak during the ﬁrst 2 weeks [12]
and provides a reservoir for brain cellular development. Thus, it
also makes the neonatal brain more vulnerable to oxidative stress,
as iron can catalyze the Fenton reaction in which H2O2 is con-
verted into highly reactive and toxic hydroxyl radicals causing cell
death [13].
The free radical, nitric oxide (NO) is well recognized as a phy-
siological mediator in the brain and plays important roles in long-
term potentiation (LTP), synaptic plasticity and activity-dependent
modiﬁcation of neural networks [14–16]. NO is enzymatically
generated from the conversion of L-arginine and oxygen by various
forms of NOS, all three NOS isoforms (eNOS, nNOS and iNOS) are
potential sources of NO in the brain. However, the mechanisms by
which elevated levels of NO leads to neuronal cell death in the HI
brain are still unclear. Interestingly, there are data suggesting that
NO can modulate cellular iron metabolism through its ability to
inactivate cellular aconitase [17,18] and activate the iron reg-
ulatory protein-1 [19] altering the homeostasis that exists between
iron uptake and cellular storage to favor uptake.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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role of increased hydroxyl radical generation in HI-mediated
neonatal brain injury and to elucidate the involvement of NO.
Using both an in vitro hippocampal slice culture model and an
in vivo model of neonatal HI we demonstrated that an NO-de-
pendent increase in hydroxyl radical generation plays an im-
portant role in the neuronal cell death associated with neonatal HI
and this is mediated via a disruption in iron homeostasis.Materials and methods
Hippocampal slice culture and OGD exposure
Neonatal rats (Sprague–Dawley, Charles River, Wilmington,
MA, USA) at postnatal day 7 (P7) were decapitated and the hip-
pocampi dissected under sterile conditions. Each hippocampus
was sliced into 400 mm slices using a Mcilwain tissue chopper
(Science Products GmbH, Switzerland). Slices were then cultured
on permeable membrane Millicell inserts (Millipore, Billerica, MA,
USA) (0.4 mm pore size) in six well plates for 6 days at 37 °C in 5%
CO2 as previously described [5,6]. Twenty-four hours before ex-
posure to OGD the culture medium was changed to neurobasal-A
and B27 supplement without antioxidants. Just prior to OGD, a
sucrose balanced salt solution (SBSS) (120 mM NaCl, 5 mM KCl,
1.25 mM NaH2PO4, 2 mM MgSO4, 2 mM CaCl2, 25 mM NaHCO3,
20 mM HEPES, 25 mM sucrose, pH of 7.3) was infused for 1 h with
5% CO2 and 10 l/h nitrogen gas. The inserts were then transferred
into deoxygenated SBSS and placed in a ProOxC system chamber
with oxygen controller (BioSpherix, NY, USA) and exposed to 0.1%
O2, 5% CO2, 94.4% nitrogen for 90 min at 37 °C. The slices were then
returned to oxygenated serum-free neurobasal medium with B27
supplement. The NOS inhibitor, L-NAME [Nω-Nitro-L-arginine
methyl ester hydrochloride] (100 mM, Sigma-Aldrich, St. Louis,
USA) were dissolved in DMSO and added to the medium 2 h before
OGD. Control experiments contained the equivalent amount of
DMSO that did not exceed 0.2% (v/v). The iron chelator, Deferox-
amine (100 mM, Sigma-Aldrich, St. Louis, USA) were dissolved in
autoclaved distilled water and added to the medium 2 h before
OGD. The hippocampal slice cultures were harvested at 4 h after
OGD for further investigation. All protocols were approved by the
Institutional Animal Care Committee at Georgia Regents
University.
Quantiﬁcation of slice culture cell death
This was carried out using propidium iodide staining, the live
slice culture ﬂuorescence images were recorded at on OGD, and
4 h after OGD groups. The evaluation of cell death was performed
using a modiﬁcation of the method of Cronberg et al. [20], as
previously described [5,6].
Aconitase activity
Aconitase activity was measured using the Aconitase Assay Kit
(Cayman Chemical, Ann Arbor, MI) [21]. Brieﬂy, hippocampal slice
cultures, or isolated rat brain tissue, were washed with ice-cold
PBS and lysed in lysis buffer containing 1% Triton X-100, 20 mM
Tris, pH 7.4, 100 mM NaCl, with 1 protease inhibitor cocktail,
and 1 phosphatase inhibitor cocktail (Sigma, St. Louis, MO, USA).
Samples were sonicated on crushed ice with two 10 s bursts and
centrifuged at 13,000g for 5 min at 4 °C. Supernatants were treated
according to the manufacturer's instructions and the protein
content was measured. Samples were diluted 1:10 in the kinase
buffer provided with the kit, and the absorbance read at 450 nm,
using a microplate reader (Synergy HT, Biotek Instruments, VT,USA). Data are present as percentage to the control.
LDH cytotoxicity assay
Cytotoxicity was evaluated by quantiﬁcation of lactate dehy-
drogenase (LDH) using a Cytotoxicity Detection Kit (Roche Applied
Science, Mannheim, Germany) in the slice culture medium as
described [5,6]. All LDH measurements were divided by the pro-
tein levels of the samples (Bradford protein assay, Bio-Rad La-
boratories, CA, USA).
Histologic evaluations
Brain tissues were washed in PBS, ﬁxed in 4% paraformalde-
hyde (RT, 1 h), then in 30% sucrose (RT, 1 h), embedded in O.C.T
embedding medium (Tissue-Tek, Sakura Finetechnical, Tokyo, Ja-
pan) and stored at 80 °C overnight. Embedded tissues were
frozen sectioned (15 mm), mounted on glass slides. Sections were
analyzed for the presence of apoptotic nuclei using the DeadEnd
Fluorometric TUNEL System (Promega, Madison, WI, USA) as de-
scribed [5,6]. Quantiﬁcation of the TUNEL stained nuclei and total
nuclei was processed by Image-Pro software and presented as a
percentage of total nuclei in the ﬁeld as described [5,6]. Tissue iron
deposition was detected in cryostat sections using the Prussian
Blue Iron Stain Kit (Sigma-Aldrich, St. Louis, USA) as previously
described [22,23]. Brieﬂy, sections were incubated in distilled
water with 1% potassium ferrocyanide and 1% hydrochloric acid
(HCl) for 15 min. After rinsing with distilled water, sections were
counterstained with neutral red. Images were then captured using
an Olympus IX70 microscope (Olympus, Japan). The iron intensity
(blue) was then quantiﬁed using ImageJ (NIH).
Immunoblot analyses
Tissue was homogenized in lysis buffer containing 1% Triton
X-100, 20 mM Tris, pH 7.4, 100 mM NaCl, with 1 protease in-
hibitor cocktail, and 1 phosphatase inhibitor cocktail (Sigma, St.
Louis, MO, USA). Lysates were centrifuged at 13,000g for 10 min at
4 °C to precipitate the debris, and the protein content in the su-
pernatant determined using the Bio-Rad protein assay (Bio-Rad
Laboratories, CA, USA). Lysate protein (20 mg/lane) was separated
using 4–20% gradient gels (Bio-Red, Hercules, CA, USA) and
transferred to PVDF membranes with the Trans-Blots Turbo™
Transfer System(Bio-Red, Hercules, CA, USA). The blots were then
probed with the appropriate antibody overnight at 4 °C. Primary
antibodies used were anti-IRP-1 (Abcam Inc., Cambridge, MA,
USA); anti-Ferritin (Abcam Inc., Cambridge, MA, USA); anti-TfR
(Abcam Inc., Cambridge, MA, USA). Blots were washed in 1 TBST
(315 min) and the appropriate secondary antibodies conjugated
to HRP (Sigma, St. Louis, MO, USA) were then added for 1 h at RT
(Thermo Scientiﬁc, Rockford, IL, USA). After further washing in
TBST (315 min) bands were visualized by chemiluminescence
(West-Femto, Pierce, Rockford, IL, USA) and quantiﬁed using a
Kodak Molecular Imaging System (Kodak, Rochester, NY, USA).
Measurement of hydroxyl radical levels
Hydroxyl radical production was measured using electron
paramagnetic resonance (EPR) spectroscopy [24] (Miniscope MS
200, Megnet tech, Berlin, Germany). Fresh tissue homogenates
protein levels were measured. Sample solutions for analysis con-
tained 35 ml homogenate and 5 ml of spin trap, 5,5-dimethey-1-
pyrroline-N-oxide (DMPO, Cayman Chemical Company, Ann Arbor,
MI). Under room temperature, the spectra were obtained using,
2 mW of microwave power, 100 kHz of modulation frequence,
2.0 G of modulation amplitude a 3 min scan time. To quantify the
Q. Lu et al. / Redox Biology 6 (2015) 112–121114amount of the waveform amplitudes generated in slice cultures of
brain hippocampi were converted into nanomoles of hydroxyl
radical per milligram/minute of protein utilizing this value.
Rat model of neonatal hypoxia–ischemia
Postnatal day 7 rat pups were anesthetized with isoﬂurane (4%
for induction; 3% for maintenance), and 20% oxygen at 1 l/min
ﬂow rate. For the duration of induction and surgery, a heated in-
duction chamber and surgical bed, (Microﬂex EZ Anesthesia Sys-
tem, Euthanex, Palmer, PA, USA), maintained core body tempera-
ture between 35–36 °C. Rectal temperature was monitored con-
tinuously using a sensitive microprobe thermometer (Physitemp
Instruments, Clifton, NJ, USA). The right common carotid artery
was exposed, permanently occluded by electrical coagulation and
incision sutured as described [5,6]. Sham operated pups received
vessel manipulation without occlusion. Immediately after surgery,
pups were placed in a temperature controlled recovery chamber toFig. 1. Oxygen glucose deprivation increases NOx levels and NO inhibition reduces cell d
to OGD in the presence of the NOS inhibitor, L-NAME (100 mM, 2 h prior to OGD). NOx lev
cell injury was also quantiﬁed by measuring changes in PI uptake ﬂuorescence in the C
changes in LDH release (D). Both PI uptake and LDH release are increased by OGD and
Representative images are shown demonstrating the TUNEL staining of apoptotic cells
(merged) nuclei than in L-NAME pretreated slices (E). The magniﬁcation used was10 .
out indicating that L-NAME decreased the level of apoptotic nuclei in response to OGD
pooled slices per experiment. *Po0.05 vs. control, †Po0.05 vs. previous group, ‡Po0.0recover for 15 min before returning to the dam for 1–2 h. For in-
duction of HI, pups were placed in a custom made, Plexiglas,
multi-chambered hypoxia device (Jarrold Manufacturing, St. Louis,
MO, USA). Chamber water bath temperature was maintained at
37 °C and each chamber infused with a calibrated mixture of
warm, humidiﬁed 8% oxygen/balance nitrogen for 2.5 h at a ﬂow
rate of 100 ml/min. Oxygen concentration was monitored (Mini-
Ox3000 oxygen analyzer, MSA Medical Products, Pittsburgh, PA,
USA) and core body temperature of pups maintained between 35
and 36 °C throughout duration of hypoxia. Sham pups were also
placed in chamber with exposure to room air only. Immediately
after hypoxia, pups were placed in a temperature regulated re-
covery chamber (36 °C), and allowed 1–2 h of recovery before
returning to dam. The NOS Inhibitor, L-NAME (30 mg/kg, Sigma-
Aldrich, St. Louis, USA) was injected i.p. 30 min prior to exposure
to hypoxia. The iron iron chelator, Deferoxamine (200 mg/kg,
Sigma-Aldrich, St. Louis, USA) was injected i.p. immediately after
exposure to hypoxia. Vehicle groups received an equivalenteath in rat hippocampal slice cultures. Rat hippocampal slice cultures were exposed
els were determined in the culture medium 2- and 4-h after OGD (A). The effect on
A1, CA3, DG regions and the whole slice 4 h after OGD (B and C) and by measuring
this is prevented by L-NAME (B–D). Slices were also subjected to TUNEL analysis.
(green) co-localized with PI staining of all the nuclei (red) resulted in more yellow
Quantiﬁcation of the percentage of apoptotic nuclei to total nuclei was also carried
(F). Data are presented as mean7S.E from 4 independent experiments using 24
5 vs. same time point without L-NAME.
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were terminated and their brain was removed, tissue homogenate
was prepared for western blot and aconitase activity analysis.
Fresh tissue homogenates also went through electron spin re-
sonance spectroscopy to measure the hydroxyl radical levels.
Using a rodent neonatal matrix (Zivic Instruments, Pittsburgh, PA,
USA), the 2 mm thick coronal sections of the brain were processed
with TTC staining and infract volume quantiﬁcation carried out as
previously described [5,6].
Statistical analysis
Statistical calculations were performed using the GraphPad
Prism V. 4.01 software. The mean7SD or SE were calculated for all
samples, and signiﬁcance was determined by either the Student's
t-test or ANOVA with the Newman–Keuls or Bonferroni post hoc
test. A value of Po0.05 was considered signiﬁcant.Results
OGD-mediated increases in nitric oxide is associated with neuronal
cell death in rat hippocampal slice cultures
Hippocampal slices from P7 rats were pretreated with the NOS
inhibitor, L-NAME (100 mM, 2 h), then exposed to OGD. Our data
indicate that NOx levels are increased after OGD and that the NOS-
inhibitor, L-NAME signiﬁcantly inhibit this increase (Fig. 1A). To
examine the effect of NOS inhibition on OGD associated cell death,
we quantiﬁed PI uptake in whole hippocampal slice. Our data
demonstrate that OGD increases PI uptake (Fig. 1B) and this was
signiﬁcantly attenuated by NOS inhibition (Fig. 1B). Similarly, NOSFig. 2. NO inhibition attenuates hydroxyl radical generation and reduces iron deposition
after OGD, hydroxyl radical levels were determined using electron paramagnetic resonan
There is a signiﬁcant increase in hydroxyl radical generation that is attenuated by L-NAM
color). Representative images are shown (B). The intensity of blue color was increased b
and C). Values are presented as mean7S.E from 4 independent experiments using 24 pinhibition signiﬁcantly decreased lactate dehydrogenase (LDH)
release (a measure of necrotic cell death) into the culture medium
(Fig. 1C). TUNEL staining also showed that inhibiting NOS, sig-
niﬁcantly reduced OGD induced neuronal cell apoptosis (Fig. 1E
and F).
OGD induced hydroxyl radical generation and iron deposition are
attenuated by NOS inhibition in rat hippocampal slice cultures
To determine if OGD increases hydroxyl radical generation in
the hippocampal slice cultures, we utilized EPR spectroscopy and
spin trapping. OGD induces a signiﬁcant increase in hydroxyl ra-
dical generation (Fig. 2A). The increased generation of the hydro-
xyl radical correlated an increase in iron deposition (Fig. 2B and C).
The increases in both hydroxyl radical generation (Fig. 2A) and
iron deposition (Fig. 2B and C) were signiﬁcantly attenuated when
the slices were pretreated with the NOS inhibitor, L-NAME.
OGD alters the expression of proteins involved in cellular iron
homeostasis in rat hippocampal slice cultures
When the iron–sulfur cluster of mitochondrial aconitase is
disrupted, the unfolded protein becomes, IRP1, a major cellular
iron-responsive element (IRE)-binding protein [25–29]. Binding to
the IRE present in the transferrin receptor (TfR) mRNA attenuates
its degradation, while binding to the ferritin mRNA IRE enhances
its translation [25–29]. Our data indicate that OGD inhibits aco-
nitase activity in hippocampal slice cultures (Fig. 3A) without al-
tering aconitase/IRP-1 protein levels (Fig. 3B). The decrease in
aconitase activity corresponded with increased protein levels of
TfR (Fig. 3C) and decreased ferritin protein levels (Fig. 3D). NOS
inhibition prevented the decrease in aconitase activity (Fig. 3A)in rat hippocampal slice cultures exposed to oxygen glucose deprivation. Four hours
ce (EPR) and the spin-trap compound, 5,5-dimethey-1-pyrroline-N-oxide (DMPO).
E (A). Slices were harvested and the amount of iron deposition determined (blue
y OGD, indicating increased iron deposition and this was attenuated by L-NAME (B
ooled slices per experiment. *Po0.05 vs. No OGD, †Po0.05 vs. OGD no treatment.
Fig. 3. NOS inhibition preserves iron homeostasis in rat hippocampal slice cultures exposed to oxygen glucose deprivation. Rat hippocampal slice cultures were exposed to
OGD in the presence of the NOS inhibitor, L-NAME (100 mM, 2 h prior to OGD), then harvested at 4 h after OGD. The effect of the OGD on aconitase activity was determined
(A). The OGD-mediated decreases in aconitase activity is attenuated by L-NAME (A). Cell extracts were also subjected to Western blot analysis to determine the effect on iron
regulatory protein-1 (IRP-1, B), ferritin (C) and transferrin receptor (TfR, D) levels. IRP-1 protein levelsa re unchanged (B). However, OGD decreases ferritin protein levels
(C) and increases TfR levels (D). These changes are attenuated by L-NAME (C and D). Values are presented as mean7S.E from 4 independent experiments using 24 pooled
slices per experiment. *Po0.05 vs. no OGD, †Po0.05 vs. OGD no treatment.
Q. Lu et al. / Redox Biology 6 (2015) 112–121116and the changes in TfR (Fig. 3C) and ferritin (Fig. 3D) protein.
Iron regulation is disrupted in the neonatal rat brain exposed to HI
Aconitase activity is decreased in the HI brain ad this is pre-
vented when NOS is inhibited with L-NAME (Fig. 4). Again, IRP-1
protein levels did not change signiﬁcantly with HI (Fig. 5A).
However, Ferritin levels were decreased (Fig. 5B) and TfR levels
were increased (Fig. 5C) in a NOS dependent manner (Fig. 5B). The
HI brain also exhibited an NOs-dependent increase in iron de-
position (Fig. 5D).
The ferric iron chelator, deferoxamine reduces iron deposition and
hydroxyl radical generation in rat hippocampal slice cultures
We next used a ferric iron chelator, deferoxamine to reduce
cellular iron toxicity. Deferoxamine reduced both the iron staining
(Fig. 6A) and elevated hydroxyl radical generation (Fig. 6B) after
OGD. This sequestration of iron correlated with a reduction in PI
uptake (Fig. 7A) and LDH release (Fig. 7B).
Deferoxamine reduces hydroxyl radical generation and infract volume
in the neonatal brain exposed to HI
Deferoxamine (200 mg/kg, I.P.) administrated immediately
after HI signiﬁcantly reduced iron deposition (Fig. 8A) and hy-
droxyl radical generation (Fig. 8B). This correlated with a reduction
in the infract volume of the right hemisphere of the neonatal rat
brain exposed to (Fig. 8C).Fig. 4. L-NAME preserves aconitase activity in the neonatal rat brain exposed to
hypoxia–ischemia. P7 neonatal rats were pre-treated with L-NAME (30 mg/kg,
30 min) then exposed to HI. Eight hours post-HI the brains were removed and the
aconitase activity in the right hemisphere determined. HI decreases aconitase ac-
tivity and this is attenuated by L-NAME. Values are presented as mean7S.D. from
5–6 animals per group. *Po0.05 vs. sham, †Po0.05 vs. HIþvehicle.Discussion
Perinatal HI represents a long-standing, refractory public
health problem [30–33]. Initially, HI results in a rapid early phase
of cellular energy failure then a secondary phase of injury that
evolves over hours to days and is accompanied by a clinical syn-
drome manifest as encephalopathy, seizures and an abnormal EEG.
The initial phase of HI is characterized by excitotoxic cell injury. In
this study we have identiﬁed a new mechanism that is involved in
the neuronal cell death associated with neonatal HI. Our data fromOGD slice cultures, and the neonatal rat brain exposed to HI, show
that NOx levels are elevated and that NOS inhibition prevents the
loss of aconitase activity, which results in the reduction of iron
deposition and hydroxyl radical generation. The neuronal cell
death in the HI brain was also dramatically decreased; suggesting
Fig. 5. L-NAME preserves iron homeostasis in the neonatal rat brain exposed to hypoxia–ischemia. P7 neonatal rats were pre-treated with L-NAME (30 mg/kg, 30 min) then
exposed to HI. Eight hours post-HI the brains were removed and the right hemisphere was subjected to Western blot analysis to evaluate changes in IRP-1 (A), ferritin (B),
and TfR (C) levels. IRP-1 protein levels are unaffected by HI (A). However, HI decreases ferritin protein levels (B) and increases TfR levels (C). These changes are attenuated by
L-NAME (B and C). In addition the iron deposition was determined. Representative images are shown (D). The intensity of blue color was increased by HI, indicating increased
iron deposition and this was attenuated by L-NAME (D). Values are presented as mean7S.D. from 5–6 animals per group. *Po0.05 vs. sham, †Po0.05 vs. HIþvehicle.
Q. Lu et al. / Redox Biology 6 (2015) 112–121 117this iron mediated hydroxyl radical neuronal cell injury is NO
dependent. Many studies show that NO is a mediator of neuronal
injury after HI [34–37] and NOS inhibition reduces infarct volume
after HI injury in the rat [38,39]. However, the source of the NO
also appears to determine if NO acts in a protective or deleterious
manner. Thus, the increase in eNOS activity that occurs im-
mediately after ischemic cerebral damage [40], is a protective as it
can improve blood supply [41,42]. Conversely, the activation of the
nNOS isoform when glutamate binds to the NMDA receptor is
thought to be deleterious [43,44]. Thus, HI injury is reduced inFig. 6. Deferoxamine reduces cell death in hippocampal slice culture exposed to oxyge
presence of the iron chelator, deferoxamine (100 mM, 2 h prior to OGD). The effect on ce
whole slice 4 h after OGD (A) and by measuring changes in LDH release (B). Both PI upta
and B). Data are presented as mean7S.E from 4 independent experiments using 24 poadult [45,46] and neonatal mice [36] deﬁcient in nNOS but in-
creased in eNOS deﬁcient mice [47]. Further, nNOS expression in
the developing brain correlates with regions of selective vulner-
ability to HI injury [48], again supporting a role for nNOS derived
NO in HI injury in the developing brain.
Despite many years of continued investigation it is still not
clear the mechanisms by which NO is involved in the brain injury
associated with HI. Some data have suggested that nNOS-derived
NO activates the p38MAPK pathway which leads to neuronal
death [49]. This is supported by our previous studies that implicaten glucose deprivation. Rat hippocampal slice cultures were exposed to OGD in the
ll injury was also quantiﬁed by measuring changes in PI uptake ﬂuorescence in the
ke and LDH release are increased by OGD and this is prevented by deferoxamine (A
oled slices per experiment. *Po0.05 vs. no OGD, †Po0.05 vs. OGD no treatment.
Fig. 7. Deferoxamine reduces iron deposition and hydroxyl radical generation in hippocampal slice culture exposed to oxygen glucose deprivation. Rat hippocampal slice
cultures were exposed to OGD in the presence of the iron chelator, deferoxamine (100 mM, 2 h prior to OGD). Deferoxamine pretreatment reduces the OGD-mediated
increase in iron deposition 4 h after OGD (A). The generation of hydroxyl radical was also measured 4 h after OGD. The OGD-mediated increase in hydroxyl radical generation
is attenuated by deferoxamine (B). Values are presented as mean7S.E from 4 independent experiments using 24 pooled slices per experiment. *Po0.05 vs. No OGD
†Po0.05 vs. OGD no treatment.
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of p38MAPK appears to be an initiator event that in turn results in
an increase in oxidative stress through its ability to phosphorylate
and activate the p47phox subunit of NADPH oxidase resulting in
increased superoxide generation [5,6]. This suggests that there
may be links between NO and reactive oxygen species generation.
ROS are continuously produced in mammalian cells during normal
aerobic metabolism, and an overabundance can threaten neuronal
survival through their ability to induce lipid peroxidation, protein
oxidation, and DNA damage [50–54]. ROS are processed by a
highly complex and integrated antioxidant defense system com-
posed of the enzymes CuZnSOD, MnSOD, catalase, GPx, andFig. 8. Deferoxamine reduces iron deposition, hydroxyl radical generation and infarct vo
given deferoxamine (200 mg/kg I.P.) immediately after HI. After HI 8 h the rat brains we
(C) were all determined in the right hemisphere. The HI mediated increase in iron depo
correlates with a reduction in infarct volume (C). *Po0.05 vs. sham, †Po0.05 vs. HIþvglutathione reductase, as well as nonenzymatic substances such as
vitamins A, C, and E and low molecular weight molecules in-
cluding reduced GSH [55]. The detoxiﬁcation of ROS is especially
important for the brain because neurons have been shown to be
particularly vulnerable to oxidative stress as a result of their lim-
ited ROS scavenging ability [55]. Indeed our prior studies have
shown that peak antioxidant defense protein levels, especially
GPx, do not occur until later developmental ages [56]. However,
the potential for antioxidant enzymes to exert neuroprotection is
complex and far from resolved. For example, adult copper zinc
superoxide dismutase (SOD1) over-expressing mice or rats have
reduced injury in a model of focal cerebral ischemic injurylume in the neonatal rat brain exposed to hypoxia-ischemia. P7 neonatal rats were
re removed, iron deposition (A), hydroxyl radical generation (B), and infarct volume
sition (A) and hydroxyl radical generation (B) are prevented by deferoxamine. This
ehicle.
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over-expressing mice have increased brain injury [60]. This ap-
pears to be due to that neonatal SOD1 transgenic mice accumu-
lating excessive levels of H2O2 after HI [60]. As this was correlated
with a decreases in the activity of GPx after the injury it has been
suggested that GPx may be the important anti-oxidant enzyme in
protection against the brain injury associated with neonatal HI
[60]. We have also shown that H2O2 levels are signiﬁcantly in-
creased by OGD in hippocampal slice cultures and by HI in the
neonatal rat brain [5]. Further, scavenging H2O2 using the ade-
noassociated viral (AAV) gene delivery of GPx1 signiﬁcantly at-
tenuates the neuronal injury associated with HI [5]. This is im-
portant as the generation of the hydroxyl radical is dependent on
the reaction of free iron with H2O2 via Fenton type chemistry. It
also suggests that NO may act at different levels in the pathway:
activating p38MAPK to stimulate NADPH oxidase activity and su-
peroxide generation and by stimulating free iron levels to increase
hydroxyl radical levels.
Iron is required for optimal neuronal growth and function
during development. Iron forms an important component of en-
zymes and proteins involved in neurotransmitter synthesis, neu-
ronal oxidative metabolism, myelin formation, and DNA synthesis
[61–63]. The ability of the element to exist in either of two stable
oxidation states (ferric, Fe3þ; ferrous, Fe2þ) is the key to its en-
zymatic activity. Unrestrained, however, iron can have adverse
consequences on cellular survival through the production of the
hydroxyl radical generated by its interaction with H2O2 [55,64–
66]. The ﬁrst 16 postnatal days in the rat are characterized by a
high rate of cell proliferation and iron requirements parallel this
rapid rate of development [67,68]. Prior work has also shown that,
in the neonatal HI rat brain, iron staining increases rapidly in re-
gions of ischemic injury, suggesting that HI induces a rapid accu-
mulation of iron in the brain [69]. Magnetic resonance imaging of
children with severe ischemic anoxic brain injury has identiﬁed
extensive areas of iron deposition in the basal ganglia and peri-
ventricular white matter [70]. Our data show that sequestering
cellular iron using deferoxamine attenuates hydroxyl radical gen-
eration and attenuates neuronal cell death suggesting that the
hydroxyl radical is a major player in HI brain injury. Deferoxamine
not only sequesters “free iron” to form an extremely stable com-
plex, it also has the ability to remove iron from ferritin and to
complex non-transferrin bound iron [71]. Thus, it mimics the ef-
fect of altering the iron regulatory and trafﬁcking proteins and is a
direct way to reduce the iron pool inside the cell. That deferox-
amine can reduce neonatal HI brain injury has been previously
reported [72,73]. Thus, our data are in agreement with these
previous studies, but go further by implicating iron mediated hy-
droxyl radical generation as being a key downstream mediator of
the neuronal cell death.
Generally, iron is loaded by transferrin which binds to TfR on
the cell membrane, after which it is passed across the membrane
by endocytosis [74]. The ferric iron (Fe3þ) is then released from
transferrin and reduced to ferrous iron (Fe2þ) for further use or/
and storage in ferritin. A major mechanism for the regulation of
iron homeostasis relies on divergent but coordinated control of
TfR-mediated iron uptake and ferritin-mediated iron sequestra-
tion. The expression of TfR and ferritin is controlled by a process
involving mRNA–protein interactions. Both TfR and ferritin
mRNA’s contain structural motifs known as “iron response ele-
ments” (IREs), which can be bound by iron regulatory protein 1
(IRP1) [25–29]. When iron levels are low, the IRP1 binds to IREs in
untranslated regions of mRNAs for TfR and ferritin, blocking de-
gradation of the former while decreasing translation of the latter
[25–29]. These processes result in a simultaneous increase in iron
uptake and a decrease in iron sequestration, forming a pool of iron
that is available for metabolic utilization. When iron levels arehigh, IRP-1 assembles a [4Fe–4S] cluster and acquires aconitase
activity, while also losing its function as a post-transcriptional
regulator [75,76]. However, IRP-1 can also be regulated by factors
other than iron levels in the cells. For example, studies have shown
that IRP-1 is highly sensitive to NO generated by NOS or by exo-
genous NO donors [77–81]. The prevailing paradigm is that NO
directly attacks the Fe–S cluster of aconitase, inducing its dis-
assembly and switching the enzyme to IRP-1 [77,78,80]. Our data
support this possibility as we ﬁnd that after HI, there is a decrease
in aconitase activity and a corresponding increase in cellular iron
uptake, mediated via increased levels of TfR protein and reduced
sequestration via a reduction in ferritin protein. In addition, our
work is in agreement with recent studies in which aerobic exercise
was found to elevate free iron levels in the hippocampus [82]
while 2,3,7,8-dibenzo-p-dioxin (TCDD) alters iron homeostasis in
urinary bladder epithelial RT4 cells [83]. In both cases the me-
chanism was found to involve NO and IRPs. It should be noted that
another IRP exists, IRP-2. IRP-2 does not assemble an Fe–S cluster
but responds to iron repletion by undergoing degradation through
the ubiquitin-proteasome pathway [26–29]. We did not evaluate
the potential role of IRP-2 in HI brain injury and it is unclear to
what extent it is involved.
In summary, elevated NO generation in the HI brain, inhibits
aconitase activity and leads to cellular iron accumulation, in-
creases in hydroxyl radical generation and neuronal cell death.
Thus, our ﬁndings have clariﬁed the mechanism by which NO
exerts its cytotoxic effect in the neonatal brain exposed to HI, and
suggests that regulating iron homeostasis is a potential clinical
strategy for protecting the neonatal brain.Acknowledgments
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